Related Experiment Video
Updated: Mar 31, 2026

In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord
Takaaki Komatsu1, Soh Katsuyama2, Hiroshi Nagase3
1Department of Pharmacology, Daiichi University of Pharmacy, 22-1 Tamagawa-cho, Minami-ku, Fukuoka, Fukuoka 815-8511, Japan; School of Pharmacy, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, USA.
Abstract:
Intrathecal (i.t.) injection of morphine-3-glucuronide (M3G), a major metabolite of morphine without analgesic actions, produces severe hindlimb scratching followed by biting and licking in mice. The M3G-induced behavioral response was inhibited dose-dependently by pretreatment with an antisera against dynorphin. However, the selective κ-opioid receptor antagonist, nor-BNI did not prevent the M3G-induced behavioral response. Dynorphin is rapidly degraded by a dynorphin-converting enzyme (cystein protease), to leucine-enkephalin (Leu-ENK). The M3G-induced behavioral response was inhibited dose-dependently by pretreatment with the antisera against Leu-ENK. We also showed that M3G co-administered with Leu-ENK-converting enzyme inhibitors, phosphoramidon and bestatin produced much stronger behavioral responses than M3G alone. Furthermore, the M3G-induced behavioral responses were inhibited dose-dependently by i.t. co-administration of the non-selective δ-opioid receptor antagonist, naltrindole or the selective δ2-opioid receptor antagonist, naltriben, whereas the selective δ1-opioid receptor antagonist, BNTX had no effect. An i.t. injection of M3G also produced a definite activation of ERK in the lumbar dorsal spinal cord. Western blotting analysis revealed that antisera against dynorphin, antisera against Leu-ENK, naltrindole or naltriben resulted in a significant blockade of ERK activation induced by M3G in the spinal cord. Taken together, these results suggest that M3G-induced nociceptive responses and ERK activation may be triggered via δ2-opioid receptors activated by Leu-ENK, which is formed from dynorphin in the spinal cord.
Insights
Morphine metabolite M3G causes scratching via dynorphin conversion to leucine-enkephalin (Leu-ENK), activating delta-2 opioid receptors and spinal ERK. Leu-ENK, not dynorphin, mediates M3G
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Morphine-3-glucuronide (M3G), a major morphine metabolite, lacks analgesic properties but induces nociceptive behaviors.
- The precise mechanisms underlying M3G-induced neurotoxicity and pain signaling remain incompletely understood.
Purpose of the Study:
- To elucidate the opioid receptor subtypes and downstream signaling pathways involved in M3G-induced behavioral responses and spinal cord activation.
- To investigate the role of dynorphin metabolism and leucine-enkephalin (Leu-ENK) in M3G-induced nociception.
Main Methods:
- Intrathecal (i.t.) administration of M3G in mice, followed by behavioral assessments (scratching, biting, licking).
- Pretreatment with antisera against dynorphin and Leu-ENK, and opioid receptor antagonists (nor-BNI, naltrindole, naltriben, BNTX).
- Assessment of ERK activation in the lumbar dorsal spinal cord using Western blotting.
Main Results:
- M3G induced dose-dependent scratching, inhibited by antisera against dynorphin and Leu-ENK, but not the kappa-opioid antagonist nor-BNI.
- Leu-ENK-converting enzyme inhibitors potentiated M3G-induced responses.
- Delta-2 opioid receptor antagonists (naltrindole, naltriben) inhibited M3G effects, while delta-1 antagonist (BNTX) did not.
- M3G activated spinal ERK, an effect blocked by Leu-ENK and delta-2 opioid receptor antagonists.
Conclusions:
- M3G-induced nociceptive responses and spinal ERK activation are mediated by Leu-ENK, derived from dynorphin.
- These effects are triggered via the activation of delta-2 opioid receptors in the spinal cord.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

